FLT3 and acute myeloid leukemia: The occurrence of internal tandem duplication (ITD) mutations in the juxtamembrane domain of the FMS-like tyrosine kinase-3 (FLT3) gene (FLT3-ITD) is identified in up to 30% of AML patients, suggesting a significantly worse clinical outcome.